PATH and WRAIR announce largest-ever controlled malaria infection

(Burness) PATH's Malaria Vaccine Initiative and the US Department of Defense's Walter Reed Army Institute of Research announced today that vaccinations are under way in a clinical trial to evaluate modifications to the vaccine regimen of GSK's RTS,S/AS01 (RTS,S) malaria vaccine candidate. The partners seek to understand if these modifications will provide equal or increased protection compared to the standard pediatric regimen.